Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular Carcinoma
Ryan Hickey(New York University), Riad Salem(Northwestern University), Vanessa L. Gates(Society of Interventional Radiology), Al B. Benson(Northwestern University), Robert J. Lewandowski(Society of Interventional Radiology), Joseph R. Kallini(Northwestern University), S. Mouli(Northwestern University), Kush Desai(Northwestern University), Michaël Abécassis(University of Arizona), Laura Kulik(Northwestern University), Bartley Thornburg(Northwestern Memorial Hospital), Talia Baker(University of Utah), Daniel Ganger(Northwestern University), Ahmed Gabr(Northwestern University)
Cited by 72
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k